0001179110-18-010076.txt : 20180801 0001179110-18-010076.hdr.sgml : 20180801 20180801203112 ACCESSION NUMBER: 0001179110-18-010076 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180730 FILED AS OF DATE: 20180801 DATE AS OF CHANGE: 20180801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howell Kelli Mari CENTRAL INDEX KEY: 0001734485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52024 FILM NUMBER: 18986318 BUSINESS ADDRESS: BUSINESS PHONE: 1-760-431-9286 MAIL ADDRESS: STREET 1: C/O ALPHATEC SPINE, INC. STREET 2: 5818 EL CAMINO REAL CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alphatec Holdings, Inc. CENTRAL INDEX KEY: 0001350653 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 202463898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5818 EL CAMINO REAL CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 760-431-9286 MAIL ADDRESS: STREET 1: 5818 EL CAMINO REAL CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml FORM 4 - X0306 4 2018-07-30 0 0001350653 Alphatec Holdings, Inc. ATEC 0001734485 Howell Kelli Mari C/O ALPHATEC SPINE, INC. 5818 EL CAMINO REAL CARLSBAD CA 92008 0 1 0 0 EVP, Clinical Strategies Common Stock 2018-07-30 4 A 0 48810 0 A 98810 D Employee Stock Option (right to buy) 2.69 2018-07-30 4 A 0 71006 0 A 2019-07-30 2028-07-30 Common Stock 71006 71006 D On July 30, 2018, issuer granted to the reporting person 48,810 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date. The option will vest 25% on the first anniversary of the grant date and thereafter in 36 equal monthly installments; provided, however, that no portion of the option shall be exercisable at any time during the first four years following the grant date unless and until the publicly-traded stock price for the securities underlying the option reaches a 30-day average trading price equal to or above $4.20 per share. Should the publicly-traded stock price for the securities underlying the option reach a 30-day average trading price at or above $4.20 per share, this pricing condition on the exercise of the option shall be satisfied, and shall terminate. /s/ Tyson Marshall by Power of Attorney 2018-08-01